4.2 Article

Amalgamation of in-silico, in-vitro and in-vivo approach to establish glabridin as a potential CYP2E1 inhibitor

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Exploring 2D-QSAR for prediction of beta-secretase 1 (BACE1) inhibitory activity against Alzheimer's disease

V Kumar et al.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2020)

Article Chemistry, Medicinal

A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors

Vinay Kumar et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Effect of chrysin on the formation of N-acetyl-p-benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes

Ravindra Babu Pingili et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2019)

Article Plant Sciences

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes

Gang Dong et al.

PHARMACEUTICAL BIOLOGY (2018)

Article Medicine, Research & Experimental

Hepatoprotective effects of litchi (Litchi chinensis) procyanidin A2 on carbon tetrachloride-induced liver injury in ICR mice

Lih-Geeng Chen et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

Article Medicine, Research & Experimental

Hepatoprotective effect of isoquercitrin against acetaminophen-induced liver injury

Wenyan Xie et al.

LIFE SCIENCES (2016)

Article Biochemistry & Molecular Biology

A polyphenolic flavonoid glabridin: Oxidative stress response in multidrug-resistant Staphylococcus aureus

Vigyasa Singh et al.

FREE RADICAL BIOLOGY AND MEDICINE (2015)

Article Chemistry, Medicinal

Evaluation of Inhibitory Effects of Caffeic acid and Quercetin on Human Liver Cytochrome P450 Activities

Himanshu Rastogi et al.

PHYTOTHERAPY RESEARCH (2014)

Article Chemistry, Medicinal

Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery

Xuan-Yu Meng et al.

Current Computer-Aided Drug Design (2012)

Review Pharmacology & Pharmacy

Paracetamol metabolism and related genetic differences

Lizi Zhao et al.

DRUG METABOLISM REVIEWS (2011)

Article Nutrition & Dietetics

Hepatoprotective Effects of Flavonoids from Shekwasha (Citrus depressa) against D-Galactosamine-Induced Liver Injury in Rats

Toshiyuki Akachi et al.

JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2010)

Review Toxicology

Role of oxidative stress in alcohol-induced liver injury

Arthur I. Cederbaum et al.

ARCHIVES OF TOXICOLOGY (2009)

Article Pharmacology & Pharmacy

Quercetin pharmacokinetics in humans

Young J. Moon et al.

BIOPHARMACEUTICS & DRUG DISPOSITION (2008)

Article Gastroenterology & Hepatology

Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice

Yongke Lu et al.

HEPATOLOGY (2008)

Article Nutrition & Dietetics

Clinical safety of licorice flavonoid oil (LFO) and pharmacokinetics of glabridin in healthy humans

Fumiki Aoki et al.

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2007)

Review Biochemistry & Molecular Biology

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

Marcella Martignoni et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)

Article Chemistry, Multidisciplinary

Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm

GS Wu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)

Article Immunology

The effect of garlic supplements on the pharmacokinetics of saquinavir

SC Piscitelli et al.

CLINICAL INFECTIOUS DISEASES (2002)

Article Medical Laboratory Technology

CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity

MG Neuman et al.

CLINICAL BIOCHEMISTRY (2001)

Article Pharmacology & Pharmacy

Drug interaction between St. John's wort and cyclosporine

GW Barone et al.

ANNALS OF PHARMACOTHERAPY (2000)

Article Pharmacology & Pharmacy

Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation

PT Manyike et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)